Some studies have analyzed both the intensity and proportion of FAP expression by immunohistochemistry (IHC); these studies suggested that stromal FAP expression promoted tumor prognosis and poor survival in some solid tumor types, including colon cancer [15] and pancreatic adenocarcinoma [16]. The gene discussed is FAP; the disease is malignant colon neoplasm.